Clindamycin Phosphate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Clindamycin Phosphate Injection (injection) from Pfizer Inc. with status Current. The shortage was first posted on Mar 21, 2023. Reported reason: Other
Shortage details
- Status
- Current
- Company
- Pfizer Inc.
- Package NDC
- 0009-0870-26
- Dosage Form
- Injection
- Presentation
- Cleocin Phosphate, Injection, Cleocin Phosphate 300 mg/2 mL (150 mg/mL) (NDC 0009-0870-26)
- Initial Posting
- Mar 21, 2023
Reason
Other